Genus plc (LON:GNS) Insider Jorgen Kokke Sells 2,186 Shares

Genus plc (LON:GNSGet Free Report) insider Jorgen Kokke sold 2,186 shares of the business’s stock in a transaction dated Monday, September 16th. The shares were sold at an average price of GBX 1,956 ($25.84), for a total value of £42,758.16 ($56,483.70).

Genus Price Performance

LON:GNS opened at GBX 1,956 ($25.84) on Tuesday. Genus plc has a 12 month low of GBX 1,478 ($19.52) and a 12 month high of GBX 2,378 ($31.41). The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.54. The business’s 50-day moving average is GBX 1,771.67 and its 200 day moving average is GBX 1,773.76. The company has a market capitalization of £1.28 billion, a P/E ratio of 16,300.00, a P/E/G ratio of 2.87 and a beta of 0.37.

Genus Increases Dividend

The business also recently disclosed a dividend, which will be paid on Friday, December 6th. Shareholders of record on Thursday, November 7th will be given a dividend of GBX 21.70 ($0.29) per share. The ex-dividend date is Thursday, November 7th. This is an increase from Genus’s previous dividend of $10.30. This represents a yield of 1.21%. Genus’s dividend payout ratio is 26,666.67%.

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft lowered their price objective on Genus from GBX 2,300 ($30.38) to GBX 2,150 ($28.40) and set a “buy” rating on the stock in a research report on Wednesday, July 17th.

View Our Latest Stock Analysis on GNS

Genus Company Profile

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

See Also

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.